- Investing Ideas
- /
- Chinese Healthcare Strong Past Earnings Growth, P/E Ratio Below 20
Chinese Healthcare Strong Past Earnings Growth, P/E Ratio Below 20
Results
6
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
6 companies
Huadong Medicine
Market Cap: CN¥67.5b
Engages in the wholesale and retail of pharmaceutical products in China and internationally.
000963
CN¥38.58
7D
4.3%
1Y
22.5%
Shanghai Pharmaceuticals Holding
Market Cap: CN¥61.1b
Shanghai Pharmaceuticals Holding Co., Ltd.
601607
CN¥18.55
7D
-0.5%
1Y
4.3%
Tibet Rhodiola Pharmaceutical Holding
Market Cap: CN¥11.9b
Tibet Rhodiola Pharmaceutical Holding Co.
600211
CN¥36.85
7D
-0.1%
1Y
3.5%
HangzhouS MedTech
Market Cap: CN¥5.0b
Engages in the research, development, production, sale, and service of endoscopic surgery equipment and accessories in China.
688581
CN¥61.62
7D
-0.7%
1Y
25.9%
Innovita Biological Technology
Market Cap: CN¥4.4b
Engages in the research and development, manufacturing, marketing, and sales of POCT rapid diagnostic products.
688253
CN¥32.01
7D
0.4%
1Y
-6.2%
Well Lead Medical
Market Cap: CN¥3.2b
Engages in the development, production, and sale of medical devices in anaesthesia, urology, endourology, respiratory, pain management, and hemodialysis areas worldwide.
603309
CN¥10.87
7D
0.8%
1Y
-6.5%